Genomics

Dataset Information

0

Zalypsis: A novel marine-derived compound with potent antimyeloma activity


ABSTRACT: Multiple Myeloma (MM) remains incurable, and new drugs with novel mechanisms of action are still needed. In this report, we have analyzed the action of Zalypsis, an alkaloid analogous to certain natural marine compounds, in MM. Zalypsis turned out to be the most potent antimyeloma agent we have tested so far, with IC50s from picomolar to low nanomolar ranges. It also showed remarkable ex vivo potency in plasma cells from patients and in MM cells in vivo xenografted in mice. Besides the induction of apoptosis and cell cycle arrest, Zalypsis provoked DNA double-strand-breaks (DSB), evidenced by an increase in phospho-Histone-H2AX and phospho-CHK2, followed by a striking overexpression of p53 in p53-wild type cell lines. In addition, in those cell lines in which p53 was mutated, Zalypsis also provoked DSB and induced cell death, although higher concentrations were required. Immunohistochemical studies in tumours also demonstrated Histone-H2AX phosphorylation and p53 overexpression. Gene expression profile studies were concordant with these results, revealing an important deregulation of genes involved in DNA-damage response. The potent in vitro and in vivo antimyeloma activity of Zalypsis uncovers the high sensitivity of tumour plasma cells to DSB, and strongly supports the use of this compound in MM patients.

ORGANISM(S): Homo sapiens

PROVIDER: GSE13662 | GEO | 2008/11/30

SECONDARY ACCESSION(S): PRJNA110213

REPOSITORIES: GEO

Similar Datasets

2009-01-13 | E-GEOD-13662 | biostudies-arrayexpress
2013-12-15 | E-MTAB-1409 | biostudies-arrayexpress
2020-05-13 | MODEL2005130001 | BioModels
2014-12-03 | E-GEOD-62534 | biostudies-arrayexpress
2012-04-03 | E-GEOD-25577 | biostudies-arrayexpress
2012-04-04 | GSE25577 | GEO
2021-10-12 | GSE183818 | GEO
2017-01-30 | GSE85570 | GEO
2017-04-17 | GSE60526 | GEO
2020-12-01 | GSE159134 | GEO